If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNext Regulatory News (NXT)

Share Price Information for Next (NXT)

Share Price is delayed by 15 minutes
Get Live Data
14,555.00    115.00 (0.80%)
Bid:
14,590.00
Ask:
14,595.00
Spread: 5.00 (0.034%)
Market Cap: £16.61b
NXT Live PriceLast checked at - London Stock Exchange

Intraday Next Share Chart

AGM Update

13 Nov 2023 12:30

RNS Number : 2647T
Next PLC
13 November 2023
 

13 November 2023

 

NEXT plc ("the Company" or "NEXT")

 

AGM Update

All resolutions put to shareholders at the NEXT 2023 Annual General Meeting ("the AGM") on 18 May 2023 were passed. A minority (20.84%) of shareholders that voted, chose not to support resolution 12 which related to the re-election of the Company's Non-Executive Chair, Mr. Michael Roney, as a director of the Company.

 

In line with the provisions of the 2018 UK Corporate Governance Code, the Company engaged in a consultation process with shareholders to gain an understanding of their reasons for voting against the re-election of Mr. Roney and now provides this update on the views received from shareholders.

 

Based on the views expressed by those shareholders before the AGM and who were identified as having voted against and who responded to the consultation, the level of votes against Mr. Roney's re-election were primarily due to him being considered as overboarded with a secondary concern relating to the gender make up of the Board.

 

The Board accepts that some investors apply a stricter voting policy than the market generally in relation to Chair and Directorship roles on the boards of listed companies. Mr. Roney provides more than enough time to his role as Chair and effectively discharges the functions and obligations of the role. He has attended all Board and Committee meetings held in the past three years. He is always available when required as was evident in the Group's response to the pandemic and his involvement in the major strategic decisions made by the Board in recent years.

 

The NEXT Nomination Committee monitors Directors' external commitments and would take appropriate action in the event of any concerns being raised about the ability of any director, including the Chair, to dedicate sufficient time to their roles.

 

Mr. Roney brings significant experience to his role at NEXT, provides clear direction and leadership to the Board and the Board believes that his continuing appointment as Chair is for the benefit of all stakeholders in the Company.

 

The Company will set out further details on these matters in the 2024 Annual Report.

 

 

Ian Blackwell

Company Secretary

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
AGMGPGWPGUPWGPW
Date   Source Headline
6th May 20217:00 amRNSTrading Statement
4th May 20215:28 pmRNSTotal Voting Rights
20th Apr 202111:24 amRNSAnnual Financial Report
7th Apr 20214:38 pmRNSDirector/PDMR Shareholding
7th Apr 20214:37 pmRNSDirector/PDMR Shareholding
6th Apr 20214:31 pmRNSDirector/PDMR Shareholding
1st Apr 202110:47 amRNSTotal Voting Rights
1st Apr 20217:00 amRNSNEXT PLC-Results for the Year Ending January 2021
24th Mar 20216:10 pmRNSHolding(s) in Company
10th Mar 202111:00 amRNSNEXT PLC - Acquisition of an Interest in Reiss
1st Mar 20219:00 amRNSTotal Voting Rights
1st Feb 20219:37 amRNSTotal Voting Rights
25th Jan 202112:59 pmRNSBlock listing Interim Review
20th Jan 202110:11 amRNSDirector/PDMR Shareholding
19th Jan 20218:51 amRNSChange in External Directorships
11th Jan 20213:53 pmRNSHolding(s) in Company
5th Jan 20214:55 pmRNSDirector/PDMR Shareholding
5th Jan 20217:00 amRNSNEXT PLC - Trading Statement
4th Jan 20219:25 amRNSTotal Voting Rights
8th Dec 20201:20 pmRNSHolding(s) in Company
1st Dec 20201:53 pmRNSTotal Voting Rights
17th Nov 20205:39 pmRNSDirector/PDMR Shareholding
16th Nov 20209:50 amRNSHolding(s) in Company
12th Nov 20205:52 pmRNSDirector/PDMR Shareholding
2nd Nov 202011:00 amRNSTotal Voting Rights
28th Oct 20202:59 pmRNSDirector/PDMR Shareholding
28th Oct 20207:00 amRNSTrading Statement
19th Oct 20204:00 pmRNSHolding(s) in Company
1st Oct 20209:26 amRNSTotal Voting Rights
25th Sep 20205:20 pmRNSReplacement:Results for Half Year Ending July 2020
21st Sep 20205:20 pmRNSDirector/PDMR Shareholding
21st Sep 20205:14 pmRNSDirector/PDMR Shareholding
18th Sep 20203:02 pmRNSDirector/PDMR Shareholding
17th Sep 20207:00 amRNSResults for the Half Year Ending July 2020
1st Sep 20201:38 pmRNSTotal Voting Rights
3rd Aug 20202:41 pmRNSTotal Voting Rights
29th Jul 20207:00 amRNSTrading Statement
24th Jul 20202:25 pmRNSBlock listing Interim Review
13th Jul 20201:07 pmRNSDirectorate Change
3rd Jul 20204:37 pmRNSHolding(s) in Company
1st Jul 20203:25 pmRNSTotal Voting Rights
1st Jun 20209:47 amRNSTotal Voting Rights
14th May 202012:30 pmRNSResult of AGM
1st May 20209:01 amRNSTotal Voting Rights
29th Apr 20207:00 amRNSTrading Statement
27th Apr 202010:55 amRNSDisclosure of Rights Attaching to Equity Shares
14th Apr 20204:40 pmRNSAnnual Financial Report
14th Apr 20207:00 amRNSNEXT Reopens Online, Warehousing and Distribution
8th Apr 20205:10 pmRNSDirector/PDMR Shareholding
3rd Apr 20206:03 pmRNSCovid Corporate Financing Facility (CCFF)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.